Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1977 Nov;39(11):1210–1216. doi: 10.1136/hrt.39.11.1210

Effect of atenolol (ICI 66 082) on coronary haemodynamics in man.

S Simonsen
PMCID: PMC483398  PMID: 588377

Full text

PDF
1213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aström H., Vallin H. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. Br Heart J. 1974 Dec;36(12):1194–1200. doi: 10.1136/hrt.36.12.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barrett A. M., Carter J., Fitzgerald J. D., Hull R., Le Count D. A new type of cardioselective adrenoceptive blocking drug. Br J Pharmacol. 1973 Jun;48(2):340P–340P. [PMC free article] [PubMed] [Google Scholar]
  3. Bussmann W. D., Rauh M., Krayenbuehl H. P. Coronary and hemodynamic effects of myocardio-selective beta-receptor blockade by ICI 50172 in the closed-chest dog. Differentiation of coronary and myocardial beta receptors. Am Heart J. 1970 Mar;79(3):347–360. doi: 10.1016/0002-8703(70)90422-9. [DOI] [PubMed] [Google Scholar]
  4. Chamberlain D. A. Effects of beta adrenergic blockade on heart size. Am J Cardiol. 1966 Sep;18(3):321–328. doi: 10.1016/0002-9149(66)90049-x. [DOI] [PubMed] [Google Scholar]
  5. Ganz W., Tamura K., Marcus H. S., Donoso R., Yoshida S., Swan H. J. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 1971 Aug;44(2):181–195. doi: 10.1161/01.cir.44.2.181. [DOI] [PubMed] [Google Scholar]
  6. Jorgensen C. R., Wang K., Wang Y., Gobel F. L., Nelson R. R., Taylor H. Effect of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise. Circulation. 1973 Dec;48(6):1173–1182. doi: 10.1161/01.cir.48.6.1173. [DOI] [PubMed] [Google Scholar]
  7. KLOCKE F. J., KAISER G. A., ROSS J., Jr, BRAUNWALD E. AN INTRINSIC ADRENERGIC VASODILATOR MECHANISM IN THE CORONARY VASCULAR BED OF THE DOG. Circ Res. 1965 Apr;16:376–382. doi: 10.1161/01.res.16.4.376. [DOI] [PubMed] [Google Scholar]
  8. Marchetti G., Merlo L., Noseda V. Mechanism of the decrease in coronary blood flow after beta-blockade in conscious dogs. Cardiovasc Res. 1972 Sep;6(5):532–540. doi: 10.1093/cvr/6.5.532. [DOI] [PubMed] [Google Scholar]
  9. Moccetti T., Halter J., Lichtlen P. Koronare und linksventrikuläre Dynamik dreier Substanzen mit unterschiedlicher -blockierender Wirkung: Propranolol, Pindolol und Practolol. Schweiz Med Wochenschr. 1972 Mar 25;102(12):422–425. [PubMed] [Google Scholar]
  10. Mueller H. S., Ayres S. M., Religa A., Evans R. G. Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics. Circulation. 1974 Jun;49(6):1078–1087. doi: 10.1161/01.cir.49.6.1078. [DOI] [PubMed] [Google Scholar]
  11. Nelson R. R., Gobel F. L., Jorgensen C. R., Wang K., Wang Y., Taylor H. L. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation. 1974 Dec;50(6):1179–1189. doi: 10.1161/01.cir.50.6.1179. [DOI] [PubMed] [Google Scholar]
  12. Parratt J. R., Grayson J. Myocardial vascular reactivity after beta-adrenergic blockade. Lancet. 1966 Feb 12;1(7433):338–340. doi: 10.1016/s0140-6736(66)91321-3. [DOI] [PubMed] [Google Scholar]
  13. Pitt B., Craven P. Effect of propranolol on regional myocardial blood flow in acute ischaemia. Cardiovasc Res. 1970 Apr;4(2):176–179. doi: 10.1093/cvr/4.2.176. [DOI] [PubMed] [Google Scholar]
  14. Roy P., Day L., Sowton E. Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability. Br Med J. 1975 Jul 26;3(5977):195–197. doi: 10.1136/bmj.3.5977.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Simaan J. Left ventricular volume as a determinant of myocardial oxygen consumption. Cardiovasc Res. 1974 Jul;8(4):534–540. doi: 10.1093/cvr/8.4.534. [DOI] [PubMed] [Google Scholar]
  16. Simonsen S. Aspects of cardiac venous flow measured by the continuous infusion thermodilution technique. Cardiology. 1977;62(1):51–62. doi: 10.1159/000169839. [DOI] [PubMed] [Google Scholar]
  17. Stein P. D., Brooks H. L., Matson J. L., Hyland J. W. Effect of beta-adrenergic blockade on coronary blood flow. Cardiovasc Res. 1968 Jan;2(1):63–76. doi: 10.1093/cvr/2.1.63. [DOI] [PubMed] [Google Scholar]
  18. Stephens J., Hamer J., Hayward R., Ead H. Proceedings: Effect of selective and non-selective beta-blockade on coronary circulation in man. Br Heart J. 1976 Mar;38(3):313–314. [PubMed] [Google Scholar]
  19. Wolfson S., Gorlin R. Cardiovascular pharmacology of propranolol in man. Circulation. 1969 Oct;40(4):501–511. doi: 10.1161/01.cir.40.4.501. [DOI] [PubMed] [Google Scholar]
  20. Wolfson S., Heinle R. A., Herman M. V., Kemp H. G., Sullivan J. M., Gorlin R. Propranolol and angina pectoris. Am J Cardiol. 1966 Sep;18(3):345–353. doi: 10.1016/0002-9149(66)90052-x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES